Asset Details
Do you wish to reserve the book?
The Distress Thermometer: Cutoff Points and Clinical Use
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Distress Thermometer: Cutoff Points and Clinical Use
Do you wish to request the book?
The Distress Thermometer: Cutoff Points and Clinical Use
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Distress Thermometer: Cutoff Points and Clinical Use
2017
Overview
To establish an optimal cutoff point for the National Comprehensive Cancer Network’s Distress Thermometer (DT) as a screening measure to identify and address psychological distress in individuals with cancer, and to examine whether distress as measured by the DT significantly changes across the treatment trajectory.
Secondary analyses of baseline data from a longitudinal parent study examining a computerized psychosocial assessment.
Three diverse comprehensive cancer centers across the United States.
836 patients with a current or past diagnosis of cancer.
Study participants were selected from a randomized clinical trial. Patients during any stage of the cancer treatment trajectory were recruited during a chemotherapy infusion or routine oncology appointment.
The Behavioral Health Status Index and the DT were administered and compared using receiver operating characteristic analyses.
Results support a cutoff score of 3 on the DT to indicate patients with clinically elevated levels of distress. In addition, patients who received a diagnosis within the 1–4 weeks prior to the assessment indicated the highest levels of distress.
Providers may wish to use a cutoff point of 3 to most efficiently identify distress in a large, diverse population of patients with cancer. In addition, results indicate that patients may experience a heightened state of distress within 1–4 weeks postdiagnosis compared to other stages of coping with cancer.
Using a brief measure of distress can help streamline the process of screening for psychosocial distress.
Publisher
Oncology Nursing Society
Subject
